Sandrine Aspeslagh

Vrije Universiteit Brussel — Belgium

Medicine · Health Sciences

35h-index4.4kcitations153works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(79), Immune Cell Function and Interaction(29), Immunotherapy and Immune Responses(19), CAR-T cell therapy research(17), Cancer Genomics and Diagnostics(16)

Publications153 total

176MO What unstructured EHR data via natural language processing (NLP) adds to oncology real-world evidence: A multi-center OMOP-CDM assessment in lung cancer
ESMO Real World Data and Digital Oncology·2025Open Access
3149P A Pan-European survey of irAEs: Clinical practice and models-of-care in 32 countries
Annals of Oncology·2025
2635P Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: Should we treat beyond two years?
Annals of Oncology·2025Open Access
Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment
The Oncologist·2025Open Access
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?
Acta Oncologica·2025· 1 citedOpen Access
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results
ESMO Real World Data and Digital Oncology·2025Open Access
Checkpoint Inhibitor Effectiveness after Corticosteroids and Second-Line Immunosuppressants for Immune-Related Adverse Events in Non-Small Cell Lung Cancer
SSRN Electronic Journal·2025Open Access
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes
RMD Open·2025· 4 citedOpen Access
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Cancer Immunology Immunotherapy·2024Open Access
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
Gynecologic Oncology·2024· 5 citedOpen Access
1844P 3-year experience of the Belgian multidisciplinary immunotoxicity board (BITOX): A nationwide initiative of the Belgian Society of Medical Oncology (BSMO)
Annals of Oncology·2024Open Access
Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies
European Journal of Cancer·2024· 6 cited
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
European Journal of Cancer·2024· 44 citedOpen Access
114P Real-world insights on pan-cancer immune checkpoint inhibitor treatment: Initial findings of a Belgian multicenter study
Immuno-Oncology Technology·2023Open Access
Événements cardiovasculaires et tumeurs malignes dans le programme de développement clinique du filgotinib pour la polyarthrite rhumatoïde jusqu’à 8,3 ans
Revue du Rhumatisme·2023
SIOG task force recommendations on skin cancer management in older patients
Journal of Geriatric Oncology·2023
1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Annals of Oncology·2023Open Access
1157P Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival
Annals of Oncology·2023· 3 citedOpen Access
2185TiP Belgian FORX trial: FOod interventions to Reduce immunotherapy toXicity
Annals of Oncology·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Aurélien Marabelle(15), Jean‐Charles Soria(13), Sophie Postel‐Vinay(12), Christophe Massard(9), Stéphane Champiat(8), Jean‐Marie Michot(7), Sylvie Rottey(7), Dirk Elewaut(6), Astrid De Meulenaere(6), Tijl Vermassen(6), Liesbeth Ferdinande(6), Bart Neyns(5), Capucine Baldini(5), Antoine Hollebecque(5), Caroline Robert(4), Émilie Lanoy(4), Vincent Ribrag(4), Anas Gazzah(4), Serge Van Calenbergh(4), Philippe Deron(4)